Triferic is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Rockwell Medical, Inc. The primary component is Ferric Pyrophosphate Citrate.
| Product ID | 57278-314_698459af-84e6-55f5-e053-2a91aa0aac82 | 
| NDC | 57278-314 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Triferic | 
| Generic Name | Ferric Pyrophosphate | 
| Dosage Form | Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2015-02-06 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206317 | 
| Labeler Name | Rockwell Medical, Inc | 
| Substance Name | FERRIC PYROPHOSPHATE CITRATE | 
| Active Ingredient Strength | 5 mg/mL | 
| Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2015-02-06 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206317 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2015-02-06 | 
| Marketing End Date | 2019-11-01 | 
| Marketing Category | NDA | 
| Application Number | NDA206317 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2015-02-06 | 
| Ingredient | Strength | 
|---|---|
| FERRIC PYROPHOSPHATE CITRATE | 5.44 mg/mL | 
| SPL SET ID: | 46ec9233-4063-4c48-e054-00144ff8d46c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 57278-314 | Triferic | FERRIC PYROPHOSPHATE | 
| 57278-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE | 
| 57278-316 | Triferic | Ferric Pyrophosphate Citrate | 
| 64811-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  TRIFERIC  86036014  4837260 Live/Registered | ROCKWELL MEDICAL, INC. 2013-08-13 |